274 related articles for article (PubMed ID: 15790353)
1. CTLA4 gene polymorphism and autoimmunity.
Gough SC; Walker LS; Sansom DM
Immunol Rev; 2005 Apr; 204():102-15. PubMed ID: 15790353
[TBL] [Abstract][Full Text] [Related]
2. Technical note: linkage disequilibrium and disease-associated CTLA4 gene polymorphisms.
Holopainen PM; Partanen JA
J Immunol; 2001 Sep; 167(5):2457-8. PubMed ID: 11509583
[TBL] [Abstract][Full Text] [Related]
3. CTLA-4 in autoimmune diseases--a general susceptibility gene to autoimmunity?
Kristiansen OP; Larsen ZM; Pociot F
Genes Immun; 2000 Feb; 1(3):170-84. PubMed ID: 11196709
[TBL] [Abstract][Full Text] [Related]
4. CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases.
Blomhoff A; Kemp EH; Gawkrodger DJ; Weetman AP; Husebye ES; Akselsen HE; Lie BA; Undlien DE
Pigment Cell Res; 2005 Feb; 18(1):55-8. PubMed ID: 15649153
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocyte antigen 4 polymorphisms and allergic asthma.
van Oosterhout AJ; Deurloo DT; Groot PC
Clin Exp Allergy; 2004 Jan; 34(1):4-8. PubMed ID: 14720255
[No Abstract] [Full Text] [Related]
6. [Costimulatory molecules in autoimmunity: role of CD28/CTLA4-CD80/CD86].
Nakajima A; Azuma M
Nihon Rinsho; 1997 Jun; 55(6):1419-24. PubMed ID: 9200926
[TBL] [Abstract][Full Text] [Related]
7. CTLA-4 and the genetic predisposition to autoimmunity.
Dallos T; Kovacs L
Bratisl Lek Listy; 2005; 106(2):55-62. PubMed ID: 16026134
[TBL] [Abstract][Full Text] [Related]
8. Genetic progress towards the molecular basis of autoimmunity.
Pearce SH; Merriman TR
Trends Mol Med; 2006 Feb; 12(2):90-8. PubMed ID: 16412690
[TBL] [Abstract][Full Text] [Related]
9. The reverse stop-signal model for CTLA4 function.
Rudd CE
Nat Rev Immunol; 2008 Feb; 8(2):153-60. PubMed ID: 18219311
[TBL] [Abstract][Full Text] [Related]
10. Modeling CTLA4-linked autoimmunity with RNA interference in mice.
Chen Z; Stockton J; Mathis D; Benoist C
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16400-5. PubMed ID: 17060611
[TBL] [Abstract][Full Text] [Related]
11. The role of CD28 and CTLA4 in the function and homeostasis of CD4+CD25+ regulatory T cells.
Boden E; Tang Q; Bour-Jordan H; Bluestone JA
Novartis Found Symp; 2003; 252():55-63; discussion 63-6, 106-14. PubMed ID: 14609212
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease.
Blomhoff A; Lie BA; Myhre AG; Kemp EH; Weetman AP; Akselsen HE; Huseby ES; Undlien DE
J Clin Endocrinol Metab; 2004 Jul; 89(7):3474-6. PubMed ID: 15240634
[TBL] [Abstract][Full Text] [Related]
13. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease.
Einarsdottir E; Söderström I; Löfgren-Burström A; Haraldsson S; Nilsson-Ardnor S; Penha-Goncalves C; Lind L; Holmgren G; Holmberg M; Asplund K; Holmberg D
Eur J Hum Genet; 2003 Jan; 11(1):81-4. PubMed ID: 12529710
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4 and its role in autoimmune thyroid disease.
Chistiakov DA; Turakulov RI
J Mol Endocrinol; 2003 Aug; 31(1):21-36. PubMed ID: 12914522
[TBL] [Abstract][Full Text] [Related]
15. An autoimmune disease-associated CTLA4 splice variant lacking the B7 binding domain signals negatively in T cells.
Vijayakrishnan L; Slavik JM; Illés Z; Rainbow D; Peterson LB; Sharpe AS; Wicker LS; Kuchroo VK
Novartis Found Symp; 2005; 267():200-12; discussion 212-8. PubMed ID: 15999808
[TBL] [Abstract][Full Text] [Related]
16. CTLA4 is differentially associated with autoimmune diseases in the Dutch population.
Zhernakova A; Eerligh P; Barrera P; Wesoly JZ; Huizinga TW; Roep BO; Wijmenga C; Koeleman BP
Hum Genet; 2005 Oct; 118(1):58-66. PubMed ID: 16025348
[TBL] [Abstract][Full Text] [Related]
17. CTLA-4 (CD152) and its involvement in autoimmune disease.
Holmberg D; Cilio CM; Lundholm M; Motta V
Autoimmunity; 2005 May; 38(3):225-33. PubMed ID: 16126511
[TBL] [Abstract][Full Text] [Related]
18. Increased total serum IgE levels in patients with asthma and promoter polymorphisms at CTLA4 and FCER1B.
Hizawa N; Yamaguchi E; Jinushi E; Konno S; Kawakami Y; Nishimura M
J Allergy Clin Immunol; 2001 Jul; 108(1):74-9. PubMed ID: 11447385
[TBL] [Abstract][Full Text] [Related]
19. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
Salomon B; Bluestone JA
Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
Bouwhuis MG; Gast A; Figl A; Eggermont AM; Hemminki K; Schadendorf D; Kumar R
Cancer Immunol Immunother; 2010 Feb; 59(2):303-12. PubMed ID: 19672595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
